FR2407208B1 - - Google Patents

Info

Publication number
FR2407208B1
FR2407208B1 FR7830625A FR7830625A FR2407208B1 FR 2407208 B1 FR2407208 B1 FR 2407208B1 FR 7830625 A FR7830625 A FR 7830625A FR 7830625 A FR7830625 A FR 7830625A FR 2407208 B1 FR2407208 B1 FR 2407208B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7830625A
Other versions
FR2407208A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
May and Baker Ltd
Original Assignee
May and Baker Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by May and Baker Ltd filed Critical May and Baker Ltd
Publication of FR2407208A1 publication Critical patent/FR2407208A1/fr
Application granted granted Critical
Publication of FR2407208B1 publication Critical patent/FR2407208B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/32—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing keto groups
    • C07C65/40—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing keto groups containing singly bound oxygen-containing groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/30—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing —CHO groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • C07D257/06—Five-membered rings with nitrogen atoms directly attached to the ring carbon atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR7830625A 1977-10-28 1978-10-27 Nouveaux derives de la n-(tetrazolyl-5)-benzamide et compositions pharmaceutiques les contenant Granted FR2407208A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB45083/77A GB1588242A (en) 1977-10-28 1977-10-28 N-(tetrazol-5-yl)-salicylamide derivatives

Publications (2)

Publication Number Publication Date
FR2407208A1 FR2407208A1 (fr) 1979-05-25
FR2407208B1 true FR2407208B1 (fr) 1981-12-18

Family

ID=10435819

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7830625A Granted FR2407208A1 (fr) 1977-10-28 1978-10-27 Nouveaux derives de la n-(tetrazolyl-5)-benzamide et compositions pharmaceutiques les contenant

Country Status (5)

Country Link
JP (1) JPS5470275A (fr)
CH (1) CH635328A5 (fr)
DE (1) DE2846891A1 (fr)
FR (1) FR2407208A1 (fr)
GB (1) GB1588242A (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4526979A (en) * 1983-07-22 1985-07-02 Merrell Dow Pharmaceuticals Inc. Carbamates and oxalamides of amino-N-(1H-tetrazol-5-yl)benzamides
US5073566A (en) * 1989-11-30 1991-12-17 Eli Lilly And Company Angiotensin ii antagonist 1,3-imidazoles and use thereas
SE0102764D0 (sv) 2001-08-17 2001-08-17 Astrazeneca Ab Compounds
GB0226930D0 (en) 2002-11-19 2002-12-24 Astrazeneca Ab Chemical compounds
TW200600086A (en) 2004-06-05 2006-01-01 Astrazeneca Ab Chemical compound
BRPI0516595A (pt) 2004-10-16 2008-09-23 Astrazeneca Ab processo para fabricar um composto, e, composto
TW200714597A (en) 2005-05-27 2007-04-16 Astrazeneca Ab Chemical compounds
BRPI0622262A2 (pt) 2005-07-09 2011-08-09 Astrazeneca Ab composto, composição farmacêutica, uso de um composto ou um sal farmaceuticamente aceitável do mesmo, e, processo para a preparação de um composto
TW200738621A (en) 2005-11-28 2007-10-16 Astrazeneca Ab Chemical process
TW200825063A (en) 2006-10-23 2008-06-16 Astrazeneca Ab Chemical compounds
SA07280576B1 (ar) 2006-10-26 2011-06-22 استرازينيكا ايه بي مركبات بنزويل أمينو سيكليل غير متجانسة بأعتبارها عوامل منشطة للجلوكوكيناز
KR20090090390A (ko) 2006-12-21 2009-08-25 아스트라제네카 아베 Ｇｌｋ 활성제로서 유용한 신규 결정 화합물
EA201100097A1 (ru) 2008-08-04 2011-10-31 Астразенека Аб Производные пиразоло[3,4]пиримидин-4-ила и их применения для лечения диабета и ожирения
GB0902406D0 (en) 2009-02-13 2009-04-01 Astrazeneca Ab Crystalline polymorphic form
GB0902434D0 (en) 2009-02-13 2009-04-01 Astrazeneca Ab Chemical process
AR076221A1 (es) * 2009-04-09 2011-05-26 Astrazeneca Ab Derivado de pirazol [4,5-e] pirimidina y su uso para tratar diabetes y obesidad
WO2010116177A1 (fr) 2009-04-09 2010-10-14 Astrazeneca Ab Dérivé de pyrazolo [4,5-e] pyrimidine et son utilisation pour traiter le diabète et l'obésité
JP5982004B2 (ja) * 2011-11-03 2016-08-31 バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＢａｙｅｒ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ ＧｍｂＨ 除草活性を有するオキシム−エーテル−置換ベンゾイルアミド類
US10785979B2 (en) * 2015-08-25 2020-09-29 Bayer Cropscience Aktiengesellschaft Substituted ketoxime benzoylamides

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2750393A (en) * 1954-12-01 1956-06-12 Sterling Drug Inc Iodinated 5-henzamidotetrazoles and preparation thereof

Also Published As

Publication number Publication date
DE2846891A1 (de) 1979-05-10
FR2407208A1 (fr) 1979-05-25
GB1588242A (en) 1981-04-23
JPS5470275A (en) 1979-06-05
CH635328A5 (en) 1983-03-31

Similar Documents

Publication Publication Date Title
FR2376420B1 (fr)
FR2378373B1 (fr)
DE2755380C3 (fr)
FR2378136B1 (fr)
FR2407208B1 (fr)
DE2803829B2 (fr)
FR2376643B1 (fr)
FR2378781B1 (fr)
FR2376309B1 (fr)
CH627910GA3 (fr)
CH632125GA3 (fr)
FR2376780B1 (fr)
FR2377297B3 (fr)
AU3353778A (fr)
FR2377927B1 (fr)
FR2377020B3 (fr)
AU495917B2 (fr)
FR2377281B3 (fr)
FR2378820B2 (fr)
FR2378638B3 (fr)
AR210643A1 (fr)
AU71461S (fr)
BE851449A (fr)
BE872973A (fr)
BE870787A (fr)

Legal Events

Date Code Title Description
ST Notification of lapse